ArticleESMO open2017

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).

Michele Orditura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.